234 related articles for article (PubMed ID: 12200455)
1. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.
Binder C; Hagemann T; Husen B; Schulz M; Einspanier A
Mol Hum Reprod; 2002 Sep; 8(9):789-96. PubMed ID: 12200455
[TBL] [Abstract][Full Text] [Related]
2. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
3. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
[TBL] [Abstract][Full Text] [Related]
4. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
[TBL] [Abstract][Full Text] [Related]
5. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
7. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Hancox RA; Allen MD; Holliday DL; Edwards DR; Pennington CJ; Guttery DS; Shaw JA; Walker RA; Pringle JH; Jones JL
Breast Cancer Res; 2009; 11(2):R24. PubMed ID: 19405959
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats.
Jeyabalan A; Kerchner LJ; Fisher MC; McGuane JT; Doty KD; Conrad KP
J Appl Physiol (1985); 2006 Jun; 100(6):1955-63. PubMed ID: 16484357
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
11. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig.
Lenhart JA; Ryan PL; Ohleth KM; Palmer SS; Bagnell CA
Endocrinology; 2002 Jan; 143(1):91-8. PubMed ID: 11751597
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
14. Enamel matrix derivative induces the expression of tissue inhibitor of matrix metalloproteinase-3 in human gingival fibroblasts via extracellular signal-regulated kinase.
Zeldich E; Koren R; Dard M; Weinberg E; Weinreb M; Nemcovsky CE
J Periodontal Res; 2010 Apr; 45(2):200-6. PubMed ID: 19909407
[TBL] [Abstract][Full Text] [Related]
15. In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells.
Paquette B; Baptiste C; Therriault H; Arguin G; Plouffe B; Lemay R
Br J Cancer; 2007 Dec; 97(11):1505-12. PubMed ID: 17987037
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
17. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Li H; Simon H; Bocan TM; Peterson JT
Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
[TBL] [Abstract][Full Text] [Related]
18. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
Leśniak-Walentyn A; Hrabia A
Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
20. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]